Abstract
Emicizumab Prophylaxis in Persons with Hemophilia A, Aged ≥50 Years, with Comorbidities - Pooled Data from Four Phase III Studies (HAVEN 1, 3, and 4, and STASEY)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have